LSA
VNDA icon

Leonteq Securities AG’s Vanda Pharmaceuticals VNDA Stock Holding History

Leonteq Securities AG’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2
Closed -$34 – 1337
2021
Q3 		$34 Sell
2
-284
-99% -$4.97K ﹤0.01% 1121
2021
Q2 		$6.15K Sell
286
-12,656
-98% -$226K ﹤0.01% 1012
2021
Q1 		$194K Buy
12,942
+3,369
+35% +$54.5K 0.01% 556
2020
Q4 		$126K Buy
+9,573
New +$115K 0.01% 643

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Leonteq Securities AG's VNDA Position: Q4 2021 in Review

Leonteq Securities AG sold out of Vanda Pharmaceuticals (VNDA) in Q4 2021, closing a stake of 2 shares — an estimated $34 sold.

Leonteq Securities AG first reported a position in VNDA in Q4 2020 and held it in 4 quarters. The position peaked at $194K in Q1 2021. 198 funds tracked by Wall St. Rank hold VNDA as of Q4 2021.

  • Leonteq Securities AG reported no remaining Vanda Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Leonteq Securities AG sold 2 Vanda Pharmaceuticals shares in Q4 2021, an estimated $34.
  • Leonteq Securities AG first reported a position in Vanda Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Leonteq Securities AG's Vanda Pharmaceuticals position peaked at $194K in Q1 2021.
  • 198 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2021.

Based on Leonteq Securities AG's 13F filing for Q4 2021, filed 26 Mar 2026.